Vega S - Search Results

1

Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M^pro and Its Antiviral Activity in Cells against SARS-CoV-2.

Mangiavacchi F, Botwina P, Menichetti E, Bagnoli L, Rosati O, Marini F, Fonseca SF, Abenante L, Alves D, Dabrowska A, Kula-Pacurar A, Ortega-Alarcon D, Jimenez-Alesanco A, Ceballos-Laita L, Vega S, Rizzuti B, Abian O, Lenardão EJ, Velazquez-Campoy A, Pyrc K, Sancineto L, Santi C. Mangiavacchi F, et al. Among authors: vega s. Int J Mol Sci. 2021 Jun 30;22(13):7048. doi: 10.3390/ijms22137048. Int J Mol Sci. 2021. PMID: 34208928 Free PMC article.

2

Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes.

Velazquez-Campoy A, Todd MJ, Vega S, Freire E. Velazquez-Campoy A, et al. Among authors: vega s. Proc Natl Acad Sci U S A. 2001 May 22;98(11):6062-7. doi: 10.1073/pnas.111152698. Epub 2001 May 15. Proc Natl Acad Sci U S A. 2001. PMID: 11353856 Free PMC article.

3

Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes.

Velazquez-Campoy A, Vega S, Freire E. Velazquez-Campoy A, et al. Among authors: vega s. Biochemistry. 2002 Jul 9;41(27):8613-9. doi: 10.1021/bi020160i. Biochemistry. 2002. PMID: 12093278

4

Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor design.

Velazquez-Campoy A, Muzammil S, Ohtaka H, Schön A, Vega S, Freire E. Velazquez-Campoy A, et al. Among authors: vega s. Curr Drug Targets Infect Disord. 2003 Dec;3(4):311-28. doi: 10.2174/1568005033481051. Curr Drug Targets Infect Disord. 2003. PMID: 14754432 Review.

5

A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 protease.

Vega S, Kang LW, Velazquez-Campoy A, Kiso Y, Amzel LM, Freire E. Vega S, et al. Proteins. 2004 May 15;55(3):594-602. doi: 10.1002/prot.20069. Proteins. 2004. PMID: 15103623

6

Thermodynamic rules for the design of high affinity HIV-1 protease inhibitors with adaptability to mutations and high selectivity towards unwanted targets.

Ohtaka H, Muzammil S, Schön A, Velazquez-Campoy A, Vega S, Freire E. Ohtaka H, et al. Among authors: vega s. Int J Biochem Cell Biol. 2004 Sep;36(9):1787-99. doi: 10.1016/j.biocel.2004.02.021. Int J Biochem Cell Biol. 2004. PMID: 15183345 Review.

7

Conformational stability of hepatitis C virus NS3 protease.

Abian O, Vega S, Neira JL, Velazquez-Campoy A. Abian O, et al. Among authors: vega s. Biophys J. 2010 Dec 1;99(11):3811-20. doi: 10.1016/j.bpj.2010.10.037. Biophys J. 2010. PMID: 21112306 Free PMC article.

8

Protein-cation interactions: structural and thermodynamic aspects.

Arias-Moreno X, Abian O, Vega S, Sancho J, Velazquez-Campoy A. Arias-Moreno X, et al. Among authors: vega s. Curr Protein Pept Sci. 2011 Jun;12(4):325-38. doi: 10.2174/138920311795906664. Curr Protein Pept Sci. 2011. PMID: 21401523 Review.

9

Studying the allosteric energy cycle by isothermal titration calorimetry.

Martinez-Julvez M, Abian O, Vega S, Medina M, Velazquez-Campoy A. Martinez-Julvez M, et al. Among authors: vega s. Methods Mol Biol. 2012;796:53-70. doi: 10.1007/978-1-61779-334-9_4. Methods Mol Biol. 2012. PMID: 22052485

10

NS3 protease from hepatitis C virus: biophysical studies on an intrinsically disordered protein domain.

Vega S, Neira JL, Marcuello C, Lostao A, Abian O, Velazquez-Campoy A. Vega S, et al. Int J Mol Sci. 2013 Jun 26;14(7):13282-306. doi: 10.3390/ijms140713282. Int J Mol Sci. 2013. PMID: 23803659 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters